Zydus Lifesciences

Zydus Lifesciences approves Rs 84 crore acquisition of Sterling Biotech’s API business

Zydus Lifesciences secures licensing and supply agreement for MRI contrast agents in the US

Zydus Lifesciences announced today that its wholly owned subsidiary, Zydus Lifesciences Global FZE, has entered into an exclusive licensing and supply agreement with Vivit Pharmaceuticals (Vivit).

Stocks to Watch: Reliance, Zydus Lifesciences, ONGC in focus today (Sept 11, 2024)

Zydus Lifesciences completes its Phase II(a) clinical trial of Usnoflast

Zydus Lifesciences gets warning letter from USFDA for injectables manufacturing facility at Jarod

Zydus Lifesciences gets warning letter from USFDA relating to its injectables manufacturing facility in Jarod

Zydus Lifesciences stock surges over 2% following Sterling Biotech stake acquisition

Zydus Lifesciences completes acquisition of 50% stake in Sterling Biotech

Stocks to Watch: Medi Assist, HCLTech, Zydus Lifesciences, Ultra Tech, HUL shares in focus Today, 27 Aug, 2024

Zydus Lifesciences shares dip 4% after acquisition of stake in Sterling Biotech

Zydus Lifesciences shares drop 3% after USFDA classification of Jarod unit as OAI

Zydus Lifesciences shares fall 2% after Gujarat unit faces regulatory action

Zydus Lifesciences gets USFDA approval for asthma treatment tablets

Zydus Lifesciences shares jump 3% on launch of mirabegron tablets in US

Zydus Lifesciences reports 26% growth in Q3 net profit